An observational study in Gall Bladder Carcinoma, sponsored by Sohag University. Recruiting at 1 site in Egypt. Open to participants aged 14 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-21.
Sponsored by Sohag University · Observational
Incidental gallbladder carcinoma :Incidence and clinical significance in specimens from routine cholecystectomies in sohag locality
Gallstone disease represents one of the commonest benign biliary disorders encountered in general surgical practice, ranging from asymptomatic cholelithiasis to biliary colic, acute cholecystitis, chronic cholecystitis, pancreatitis, cholangitis, and obstructive jaundice. Laparoscopic cholecystectomy is widely accepted as the standard definitive treatment for symptomatic gallstone disease and constitutes one of the most frequently performed abdominal operations worldwide This study aims to determine the incidence of incidental gallbladder carcinoma among routine cholecystectomy specimens in Sohag and to evaluate its clinicopathological characteristics, associated risk factors, histopathological staging, and clinical significance regarding postoperative management, referral, and need for further surgical intervention.
255 studies on the registry are indexed under Gallbladder Neoplasms; 61 are open to participants now.
This study's planned enrollment of 100 is below the median of 230 across 54 observational studies indexed under Gallbladder Neoplasms.
Browse Gallbladder Neoplasms studies →Sohag University is the lead sponsor of 1,218 studies on the registry; 627 are open to participants now.
Counted across the registry records on this site, refreshed daily.
The study will involve patients undergoing elective or emergency cholecystectomy at Sohag University Hospital for presumed benign gallbladder disease, including symptomatic cholelithiasis, acute calculous cholecystitis, chronic calculous cholecystitis, gallbladder mucocele, empyema, or gallbladder polyps without confirmed preoperative malignancy
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients refusing participation or postoperative follow-up.
-
Other: histopathology of gall bladder
histopathology of gall bladder after cholycystectomy
incidence of gallbladder carcinoma
incidence of gallbladder carcinoma in histopathology
Time frame: 6 months
Plan to share: Undecided — Incidental gallbladder carcinoma :Incidence and clinical significance in specimens from routine cholecystectomies in sohag locality
No publications or documents are linked to this record.
Started Sep 2026 (actual). Primary completion is estimated for May 2027, 8 months after the start.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.